Travere Therapeutics TVTX
NASDAQ TVTX
$58.88 -1.11 (-1.85%)
At close: Sep 30, 2026 · 4:00 PM EDT

Travere Therapeutics (TVTX) Receivables - Other (2014 - 2018)

Updated

Travere Therapeutics' Receivables - Other was $562,500 in Q2 2018.

Analysis

Travere Therapeutics (TVTX) Receivables - Other (2014 - 2018) Analysis & Trends

  • The Q2 2018 figure marks the highest quarterly Receivables - Other since Q2 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Travere Therapeutics 5.55 Bn 5.14 Bn 167.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2018 562,500.00
Jun 30, 2014 5.96 Mn
API Access

Travere Therapeutics Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=TVTX&period=max&api_key=YOUR_API_KEY